In addition, MSCs-Exo could facilitate VEGF suppression and inhibit the growth of oral squamous cell carcinoma [81] and prostate cancer cells by preventing VEGF production and NF-κB signaling [82]. The gene discussed is VEGFA; the disease is prostate carcinoma.